PROCEPT BioRobotics Corp
PRCT · Industrials · Nasdaq · As of 10 Sep 2026
- FundamentalsBalanced
- ValueNot enough data yet
- News flowBalanced
- MomentumWeak
- SafetyStrong
Overall confidence 58/100 — a solid read; one perspective is still filling in
Discovery Gap: Low (0/100) · Gap confidence 30/100The market has largely caught up to the documented story.
This month at a glance
AIR Score™ change: 0AIR Score™ held steady this month.
Cycle window9 Sep 2026 → 10 Sep 2026
MoversNothing moved meaningfully this month.
Evidence timeline
- [8-K 2.02] PROCEPT BioRobotics Corp — Results of Operations and Financial ConditionSEC · SEC EDGARAug 4, 2026 · 8-K
- [8-K 2.02] PROCEPT BioRobotics Corp — Results of Operations and Financial ConditionSEC · SEC EDGARApr 29, 2026 · 8-K
- [8-K 5.02] PROCEPT BioRobotics Corp — Departure/Election of Directors or Principal OfficersSEC · SEC EDGARMar 5, 2026 · 8-K
- [8-K 2.02] PROCEPT BioRobotics Corp — Results of Operations and Financial ConditionSEC · SEC EDGARFeb 25, 2026 · 8-K
- [8-K 2.02] PROCEPT BioRobotics Corp — Results of Operations and Financial ConditionSEC · SEC EDGARNov 4, 2025 · 8-K
- [8-K 5.02] PROCEPT BioRobotics Corp — Departure/Election of Directors or Principal OfficersSEC · SEC EDGARSep 15, 2025 · 8-K
- [8-K 2.02] PROCEPT BioRobotics Corp — Results of Operations and Financial ConditionSEC · SEC EDGARAug 6, 2025 · 8-K
- [8-K 2.02] PROCEPT BioRobotics Corp — Results of Operations and Financial ConditionSEC · SEC EDGARJul 23, 2025 · 8-K
- [8-K 5.02] PROCEPT BioRobotics Corp — Departure/Election of Directors or Principal OfficersSEC · SEC EDGARJul 23, 2025 · 8-K
- [8-K 2.02] PROCEPT BioRobotics Corp — Results of Operations and Financial ConditionSEC · SEC EDGARApr 24, 2025 · 8-K
- [8-K 2.02] PROCEPT BioRobotics Corp — Results of Operations and Financial ConditionSEC · SEC EDGARFeb 25, 2025 · 8-K
- [8-K 8.01] PROCEPT BioRobotics Corp — Other EventsSEC · SEC EDGAROct 29, 2024 · 8-K
Ask AIR
What would change our view
A weaker balance sheet in the next filing cycle, a material regulatory setback, or a new evidence cluster that re-opens a distance between filings and attention would move the score, and the page would show which one did.
Research, not tips. No buy/sell recommendations, no price forecasts. Every score is derived from public filings and market data — figures round to whole numbers and refresh each trading day.